Survey efficacy of Melissa officinalis on premature ventricular contraction in Persons with palpitation referring to Dr. Heshmat Rasht Hospital

Phase 2

Recruiting

• Conditions: premature ventricular contraction.; Ventricular premature depolarization; I49.3

• Registration Number: IRCT20180205038626N4
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Tumors use tranquilizers
no addiction
no history of allergy to herbal medicines
palpitations
ages 18-60
PVC less than 15%

Exclusion Criteria

Pvc in the field of ischemic heart disease
patients with lupus erythematosus
heart failure
ACS and cardiologist confirmed
psychotic patients and serious psychiatric illnesses certified by a psychiatrist
endocrine problems
pregnancy
Treated with hypnosis and treated with anti-anxiety and sedative drugs within 10 days before the study
lack of hypothyroidism
thyroid dysfunction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Premature ventricular contraction. Timepoint: At the end of the 3-month period, both rituals and echo cancers will be performed and the amount of pvc reduction will be evaluated by the cardiologist. Method of measurement: Echocardiography, Holler rhythm and ECG.